Repurposing rosiglitazone for beta-thalassemia/hemoglobin E therapy in the circumstances of ubiquitin-proteasome dysregulation
Ontology highlight
ABSTRACT: CD34+ stem cells treated with rosiglitazone in beta-thalassemia/hemoglobinE
ORGANISM(S): Homo Sapiens (human)
SUBMITTER: Wararat Chiangjong
PROVIDER: PXD054655 | JPOST Repository | Wed Aug 07 00:00:00 BST 2024
REPOSITORIES: jPOST
ACCESS DATA